VABIOTECH - a leading vaccine manufacturer in Vietnam
After two decades of development, VABIOTECH is now one of the leading companies in researching, manufacturing and trading vaccines and biological products in Vietnam.
When Vietnam recorded its first case of COVID-19 in early 2020, the company collaborated with the UK’s University of Bristol to do research on a potential viral-vector-based vaccine against SARS-CoV-2. In the photo: Researchers work on developing a COVID-19 vaccine. (Photo: VNP/VNA)
Young technicians work in the lab. (Photo: VNP/VNA)
Taking samples for new vaccine research at VABIOTECH (Photo: VNP/VNA)
Researchers work on developing vaccine. (Photo: VNP/VNA)
A technician takes samples to test the quality of cell suspension. (Photo: VNP/VNA)
A row of vaccine vials (Photo: VNP/VNA)
VABIOTECH is one of the leading companies in researching, manufacturing and trading vaccines and biological products in Vietnam. (Photo: VNP/VNA)
VABIOTECH owns and operates a system of facilities and equipment which meets international standards. (Photo: VNP/VNA)
The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins.
The Standing Board of the National Steering Committee for COVID-19 Prevention and Control has agreed to create the best possible conditions for the trial of homegrown vaccines.
VABIOTECH, one of Vietnam’s leading pharmaceutical companies, and the Russian Direct Investment Fund (RDIF) on July 21 announced the production of a test batch of the Russian Sputnik V vaccine against the coronavirus in Vietnam.
VABIOTECH, one of Vietnam’s leading pharmaceutical companies, and the Russian Direct Investment Fund (RDIF) have announced the production of a test batch of the Russian Sputnik V vaccine against the coronavirus in Vietnam.